Hiroko Yamamoto

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

Yukito Shinohara, Yasuo Katayama, Shinichiro Uchiyama et al. · The Lancet Neurology · 2010 · 487 citations

Pharmacy, Neurology, Pharmacotherapy +10

Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B

Ada Congrains, Kei Kamide, Ryousuke Oguro et al. · Atherosclerosis · 2011 · 336 citations · Full text

Medicine, Genetics, Molecular Genetics +10

DNA Binding Specificity of the CCAAT/Enhancer-binding Protein Transcription Factor Family

Shigehiro Osada, Hiroko Yamamoto, Tsutomu Nishihara et al. · Journal of Biological Chemistry · 1996 · 300 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Effects of colony stimulating factors on isolated microglia in vitro

Akio Suzumura, Makoto Sawada, Hiroko Yamamoto et al. · Journal of Neuroimmunology · 1990 · 216 citations

Life Sciences, Immunology, Neuroscience +12

N,N-Dimethylformamide-stabilized gold nanoclusters as a catalyst for the reduction of 4-nitrophenol

Hiroko Yamamoto, Hiroki Yano, Haruki Kouchi et al. · Nanoscale · 2012 · 211 citations

Natural Sciences, Chemical Engineering, Chemistry +17